Dark Mode Light Mode
'Mental health is real ... Do not ignore signs'
The CDC advisor discusses the narrow use of the COVID-19 booster shot.
OHIO

The CDC advisor discusses the narrow use of the COVID-19 booster shot.

Spread the love


Reuters/Tami Chapel/File Photo in September 2014, the disease control of Atlanta, Georgia, and the general view of the prevention headquarters. On Tuesdays, the US external vaccine expert panel for US disease control and prevention discussed the narrow recommendation of the use of Covid-19 BOOSTER Shots at the new Trump administration's first meeting.

Reuters/Tami Chapel/File Photo

The general view of the disease control and the prevention headquarters center in Atlanta, Georgia, in September 2014 is a general view of the vaccine expert’s external panel for the US disease control and prevention on Tuesday. I discussed.

On Tuesdays, the vaccine expert at the US Centers for Disease Center discussed the narrow recommendations for the use of the Covid-19 booster shots for the upcoming vaccination campaign at the first meeting of the new Trump administration.

The panel has raised the idea of ​​encouraging an updated vaccine for a vulnerable population at risk of serious Covid-19 during the 2025-2026 season. Most panel members did not oppose, but they expressed concern about problems that were difficult to implement approach.

One of the panel members, Denise Jamieson, has a history that the United States cannot implement such a variable recommendation, and Covid is still a major cause of death among adults and children.

Another panelist, Jamie Loehr, said, “I am concerned about the validity and the message that the message can send even if it is very in favor of considering the risk -based approach.

The majority of the CDC working group preferred risk -based approaches compared to the recommendations, not at the current short distance. The panel will vote for official recommendations at the June meeting.

The agency recommends that an individual with an updated Covid-199 vaccine, regardless of the previous vaccination of the disease for more than six months.

CITI analysts said they would eat potential risk -based recommendations for selling coved vaccines for pharmaceuticals such as Pfizer and Moderna.

The advisory committee on vaccination practices will vote for the recommendations of three vaccine use, respiratory cell fusion viruses, chikungunya, mosquito -mediated diseases and meningococcal vaccines discussed at a two -day meeting.

The panel will also discuss more than 700 people this year among residents who have not been vaccinated by Texas and New Mexico this year.

The meeting was suddenly delayed a few days after the long -time vaccine conference, Robert F. Kennedy Jr., became the head of the Ministry of Health and Welfare. CDC, a part of HHS, said the meeting was delayed to allow public opinions.

Citi Analysts said, “Today’s long -delayed ACIP meeting is to think of it as an initial sign of a more comfortable CDC under the HHS.

The CDC director usually signs the recommendation of the panel before it is implemented, but the agency does not currently have.

President Donald Trump was nominated for Susan Monarez to lead the CDC after withdrawing the name of former Republican Congressman and the vaccine critic, Dave Weldon, but the Senate has not yet been confirmed.

A HHS spokesman said CDC’s head of Matthew Buzzelli said he would put weight on the recommendation instead.




Source link

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Add a comment Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

'Mental health is real ... Do not ignore signs'

Next Post

OHIO